BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12625027)

  • 1. New hope in the treatment of painful symptoms in depression.
    Briley M
    Curr Opin Investig Drugs; 2003 Jan; 4(1):42-5. PubMed ID: 12625027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with dual action antidepressants in different chronic pain syndromes.
    Briley M
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S21-5. PubMed ID: 15378667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of depression in the presence of pain symptoms.
    Mohr P; Bitter I; Svestka J; Seifritz E; Karamustafalioglu O; Koponen H; Sartorius N
    Psychiatr Danub; 2010 Mar; 22(1):4-13. PubMed ID: 20305585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Painful physical symptoms in depression: a clinical challenge.
    Wise TN; Fishbain DA; Holder-Perkins V
    Pain Med; 2007 Sep; 8 Suppl 2():S75-82. PubMed ID: 17714118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J; Rybakowski J
    Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of duloxetine on primary pain symptoms in Parkinson disease.
    Djaldetti R; Yust-Katz S; Kolianov V; Melamed E; Dabby R
    Clin Neuropharmacol; 2007; 30(4):201-5. PubMed ID: 17762316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine versus venlafaxine in the treatment of unipolar and bipolar depression.
    Serafini G; Pompili M; Del Casale A; Mancini M; Innamorati M; Lester D; Girardi P; Tatarelli R
    Clin Ter; 2010; 161(4):321-7. PubMed ID: 20931154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG; Kajdasz DK; Desaiah D; Haddad PM
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.
    Delgado PL
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():16-21. PubMed ID: 24921678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.